TY - JOUR
T1 - The role of adjuvant and neoadjuvant therapy in gastrointestinal stromal tumors
AU - Von Mehren, Margaret
PY - 2008/7
Y1 - 2008/7
N2 - Treatment for gastrointestinal stromal tumors, formerly limited to surgery, now is a combination of surgery and tyrosine kinase inhibitors therapy. Combination therapy is safe and improves outcomes, particularly in the adjuvant setting.
AB - Treatment for gastrointestinal stromal tumors, formerly limited to surgery, now is a combination of surgery and tyrosine kinase inhibitors therapy. Combination therapy is safe and improves outcomes, particularly in the adjuvant setting.
KW - Adjuvant
KW - Gastrointestinal stromal tumors
KW - Imatinib
KW - Neoadjuvant
KW - Sunitinib
UR - http://www.scopus.com/inward/record.url?scp=47249141755&partnerID=8YFLogxK
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=purepublist2023&SrcAuth=WosAPI&KeyUT=WOS:000257379500013&DestLinkType=FullRecord&DestApp=WOS
U2 - 10.1097/CCO.0b013e328302ed82
DO - 10.1097/CCO.0b013e328302ed82
M3 - Review article
C2 - 18525339
SN - 1040-8746
VL - 20
SP - 428
EP - 432
JO - Current Opinion in Oncology
JF - Current Opinion in Oncology
IS - 4
ER -